GlassScriptPhysician profile
Sami Mohammod Hafsa
NPI 1023679024
$5,687.32
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.58 · 2022: $76.62 · 2023: $2,740 · 2024: $2,854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,517 · Travel and Lodging: $1,310 · Education: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,517.04 |
| Travel and Lodging | $1,310.16 |
| Education | $766.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,993.78 | 2023-2024 | Vercise, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $1,318.24 | 2023-2024 | Omnia, Senza |
| Abbott Laboratories | $1,126.41 | 2023-2024 | Proclaim, Eterna |
| Biotronik Nro, INC. | $280.94 | 2023-2024 | Prospera, Biotronik |
| Spr Therapeutics, INC | $267.03 | 2023-2024 | Sprint Pns System |
| Vertos Medical, INC. | $177.39 | 2023 | Mild Device Kit |
| Mml US, INC. | $153.54 | 2024 | Reactiv8 |
| Nalu Medical, INC. | $95.73 | 2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $39.78 | 2022 | |
| Si-Bone, INC. | $36.33 | 2024 | |
| Abbvie INC. | $33.77 | 2023 | |
| Collegium Pharmaceutical, INC. | $29.15 | 2023-2024 | Xtampza |
| Cvrx, INC. | $26.68 | 2023 | Barostim Neo System |
| Fisher & Paykel Healthcare INC | $23.68 | 2023 | Fisher & Paykel Healthcare |
| Draeger Medical Systems, INC | $22.00 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $16.58 | 2020 | |
| Almatica Pharma LLC | $15.78 | 2023 | Gralise |
| Eagle Pharmaceuticals, INC. | $15.67 | 2023 | |
| Cranial Technologies, INC | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Hafsa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.